{"transactions":[{"id":2785997,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-09","kind":"gift","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Gift of shares of Common Stock to charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F12","text":"Following the transactions reported on this Form 4, the Reporting Persons as listed in this Form 4 are the beneficial owners in the aggregate of 10,060,657 shares of Common Stock for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, representing a 27.8% ownership interest in the Issuer based on total shares outstanding of 36,213,969 as of March 5, 2021, such shares outstanding as reported in the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2020."}],"balance_after":12585,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785996,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":1783578,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Shares of Common Stock acquired through pro rata distribution for no consideration by MRX Partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine Partners, L.P. (\"MonoLine\"), MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the \"Monoline Entities\" and each individually a \"Monoline Entity\". Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the manager of MRX Partners and general partner of each of the other Monoline Entities. Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are beneficially owned by MonoLine."}],"balance_after":1948578,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785995,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":2249077,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration of shares of common stock of the Issuer (\"Common Stock\") by the applicable MonoLine Entity or Monosol (each as defined below), as indicated in the respective footnotes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine Partners, L.P. (\"MonoLine\"), MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the \"Monoline Entities\" and each individually a \"Monoline Entity\". Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the manager of MRX Partners and general partner of each of the other Monoline Entities. Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These securities are beneficially owned by MRX Partners."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785994,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":40404,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration of shares of common stock of the Issuer (\"Common Stock\") by the applicable MonoLine Entity or Monosol (each as defined below), as indicated in the respective footnotes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are beneficially owned by MonoSol Rx Genpar, L.P. (\"Monosol\"). Bratton is the general partner of Monosol. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by Monosol."}],"balance_after":47051,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785993,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":97598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration of shares of common stock of the Issuer (\"Common Stock\") by the applicable MonoLine Entity or Monosol (each as defined below), as indicated in the respective footnotes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine Partners, L.P. (\"MonoLine\"), MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the \"Monoline Entities\" and each individually a \"Monoline Entity\". Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the manager of MRX Partners and general partner of each of the other Monoline Entities. Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are beneficially owned by Monoline III."}],"balance_after":2657943,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785992,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":564160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration of shares of common stock of the Issuer (\"Common Stock\") by the applicable MonoLine Entity or Monosol (each as defined below), as indicated in the respective footnotes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine Partners, L.P. (\"MonoLine\"), MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the \"Monoline Entities\" and each individually a \"Monoline Entity\". Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the manager of MRX Partners and general partner of each of the other Monoline Entities. Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are beneficially owned by Monoline II."}],"balance_after":3468747,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":2785991,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"MonoLine Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141267,"kind":"organization","name":"MonoLine RX, L.P.","position":3,"cik":"0001410626","reported_name":"MonoLine RX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141268,"kind":"organization","name":"MonoLine RX II, L.P.","position":4,"cik":"0001410625","reported_name":"MonoLine RX II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141269,"kind":"organization","name":"MonoLine RX III, L.P.","position":5,"cik":"0001747169","reported_name":"MonoLine RX III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141270,"kind":"organization","name":"MonoSol Rx Genpar, L.P.","position":6,"cik":"0001747548","reported_name":"MonoSol Rx Genpar, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141271,"kind":"organization","name":"MRX Partners, LLC","position":7,"cik":"0001746904","reported_name":"MRX Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":8,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":9,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:20:20.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":524675,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration of shares of common stock of the Issuer (\"Common Stock\") by the applicable MonoLine Entity or Monosol (each as defined below), as indicated in the respective footnotes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine Partners, L.P. (\"MonoLine\"), MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the \"Monoline Entities\" and each individually a \"Monoline Entity\". Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the manager of MRX Partners and general partner of each of the other Monoline Entities. Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director and President of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Monoline Rx."}],"balance_after":1688639,"source":{"system":"sec-edgar","filing":"0001214659-21-003203","document":"marketforms-51911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410625/000121465921003203/marketforms-51911.xml","form_type":"4"}},{"id":3860749,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":85440,"kind":"person","name":"BRATTON DOUGLAS K","position":1,"cik":"0001281933","reported_name":"BRATTON DOUGLAS K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141266,"kind":"organization","name":"MonoLine Partners, L.P.","position":2,"cik":"0001747211","reported_name":"Monoline Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":98891,"kind":"organization","name":"Bratton Capital Management, L.P.","position":3,"cik":"0001723787","reported_name":"Bratton Capital Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141272,"kind":"organization","name":"Bratton Capital Inc.","position":4,"cik":"0001723783","reported_name":"Bratton Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T14:59:47.000Z","date":"2018-07-24","kind":"purchase","acquired":true,"shares":165000,"price":15,"value":2475000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by MonoLine Partners, L.P. (\"MonoLine\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned, as indicated, by MonoLine, MRX Partners, LLC (\"MRX Partners\"), MonoLine Rx, L.P. (\"Monoline Rx\"), MonoLine Rx II, L.P. (\"Monoline II\"), and MonoLine Rx III, L.P. (\"Monoline III\"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II,  and Monoline III are referred to herein collectively as the \"Monoline Entities\".  Bratton Capital Management, L.P. (\"Bratton Capital Management\") is the general partner of each of the Monoline Entities.  Bratton Capital, Inc. (\"Bratton\") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by the Monoline Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein."}],"balance_after":165000,"source":{"system":"sec-edgar","filing":"0000897423-18-000055","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281933/000089742318000055/edgar.xml","form_type":"4"}}]}